語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Alzheimer's disease II
~
SpringerLink (Online service)
Alzheimer's disease II
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Alzheimer's disease II/ edited by Michael S. Wolfe.
其他作者:
Wolfe, Michael S.
出版者:
Cham :Springer International Publishing : : 2017.,
面頁冊數:
vii, 202 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:
Springer eBooks
標題:
Alzheimer's disease. -
電子資源:
http://dx.doi.org/10.1007/978-3-319-59460-6
ISBN:
9783319594606
Alzheimer's disease II
Alzheimer's disease II
[electronic resource] /edited by Michael S. Wolfe. - Cham :Springer International Publishing :2017. - vii, 202 p. :ill. (some col.), digital ;24 cm. - Topics in medicinal chemistry,241862-2461 ;. - Topics in medicinal chemistry ;8..
Targets and Strategies Toward the Development of Alzheimer Therapeutics -- The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer's Disease -- γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer's Disease -- Inhibitors of Tau-Phosphorylating Kinases -- Microtubule-Stabilizing Agents for Alzheimer's and Other Tauopathies -- PET Imaging Agents for Alzheimer's Disease.
Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors.
ISBN: 9783319594606
Standard No.: 10.1007/978-3-319-59460-6doiSubjects--Topical Terms:
581461
Alzheimer's disease.
LC Class. No.: RC523
Dewey Class. No.: 616.8311
Alzheimer's disease II
LDR
:02641nam a2200325 a 4500
001
885215
003
DE-He213
005
20170515143859.0
006
m d
007
cr nn 008maaau
008
180530s2017 gw s 0 eng d
020
$a
9783319594606
$q
(electronic bk.)
020
$a
9783319594590
$q
(paper)
024
7
$a
10.1007/978-3-319-59460-6
$2
doi
035
$a
978-3-319-59460-6
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC523
072
7
$a
PSB
$2
bicssc
072
7
$a
SCI013020
$2
bisacsh
082
0 4
$a
616.8311
$2
23
090
$a
RC523
$b
.A478 2017
245
0 0
$a
Alzheimer's disease II
$h
[electronic resource] /
$c
edited by Michael S. Wolfe.
260
$a
Cham :
$c
2017.
$b
Springer International Publishing :
$b
Imprint: Springer,
300
$a
vii, 202 p. :
$b
ill. (some col.), digital ;
$c
24 cm.
490
1
$a
Topics in medicinal chemistry,
$x
1862-2461 ;
$v
24
505
0
$a
Targets and Strategies Toward the Development of Alzheimer Therapeutics -- The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer's Disease -- γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer's Disease -- Inhibitors of Tau-Phosphorylating Kinases -- Microtubule-Stabilizing Agents for Alzheimer's and Other Tauopathies -- PET Imaging Agents for Alzheimer's Disease.
520
$a
Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors.
650
0
$a
Alzheimer's disease.
$3
581461
650
0
$a
Alzheimer's disease
$x
Chemotherapy.
$3
677833
650
1 4
$a
Chemistry.
$3
593913
650
2 4
$a
Medicinal Chemistry.
$3
668872
650
2 4
$a
Pharmaceutical Sciences/Technology.
$3
768561
650
2 4
$a
Receptors.
$3
787639
650
2 4
$a
Neurosciences.
$3
593561
700
1
$a
Wolfe, Michael S.
$3
1142253
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
830
0
$a
Topics in medicinal chemistry ;
$v
8.
$3
884548
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-59460-6
950
$a
Chemistry and Materials Science (Springer-11644)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入